Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

NPCi discusses Anticholinergics in COPD

The National Prescribing Centre (NPC) has published a Rapid Review discussing in detail the current concerns about inhaled anticholinergics in people with COPD and an increase in cardiovascular events.

The article details the background to the current concerns, provides a detailed interpretation of the latest information and highlights the limitations in the current data.

Action: Clinicians will find this article useful in reassuring patients. It is thorough and of the usual high standard expected of the NPC.

Share 'NPCi discusses Anticholinergics in COPD' on Email Share 'NPCi discusses Anticholinergics in COPD' on Delicious Share 'NPCi discusses Anticholinergics in COPD' on Digg Share 'NPCi discusses Anticholinergics in COPD' on Facebook Share 'NPCi discusses Anticholinergics in COPD' on Google+ Share 'NPCi discusses Anticholinergics in COPD' on reddit Share 'NPCi discusses Anticholinergics in COPD' on StumbleUpon Share 'NPCi discusses Anticholinergics in COPD' on Twitter

atomic-wealth

No Comments to “NPCi discusses Anticholinergics in COPD”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,657 spam comments.

atomic-wealth
fond-illness
summer